Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma
NCT01719744
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Advanced
Metastatic
Soft Tissue Sarcoma
Interventions
DRUG:
ENMD-2076
Sponsor
University Health Network, Toronto